ChiefBrief Daily Podcast
Sepsis remains the leading cause of in-hospital mortality, but the strategic landscape for CMOs is shifting rapidly in 2026 with the first FDA 510(k) clearance of a continuous AI sepsis monitoring system and emerging evidence that age-stratified treatment approaches may outperform one-size-fits-all bundle protocols. CMOs must now reconcile bundle compliance discipline with a new generation of predictive tools, novel biomarker panels, and biology-informed care pathways that challenge longstanding assumptions about uniform sepsis management.
43 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der ChiefBrief Daily Podcast-Community!